YOUSIF CAPITAL MANAGEMENT, LLC has added 50,398 shares of $AHR to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $AHR.
AMERICAN HEALTHCARE REIT Hedge Fund Activity
We have seen 273 institutional investors add shares of AMERICAN HEALTHCARE REIT stock to their portfolio, and 203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYAL BANK OF CANADA added 5,961,767 shares (+2984.1%) to their portfolio in Q4 2025, for an estimated $280,560,755
- WCM INVESTMENT MANAGEMENT, LLC added 3,408,275 shares (+inf%) to their portfolio in Q4 2025, for an estimated $160,393,421
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,366,007 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $158,404,289
- NORGES BANK added 1,870,143 shares (+271.7%) to their portfolio in Q4 2025, for an estimated $88,008,929
- PRINCIPAL FINANCIAL GROUP INC removed 1,736,874 shares (-19.4%) from their portfolio in Q4 2025, for an estimated $81,737,290
- FMR LLC added 1,715,105 shares (+48.3%) to their portfolio in Q4 2025, for an estimated $80,712,841
- BALYASNY ASSET MANAGEMENT L.P. added 1,678,850 shares (+354.0%) to their portfolio in Q4 2025, for an estimated $79,006,681
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMERICAN HEALTHCARE REIT Insider Trading Activity
AMERICAN HEALTHCARE REIT insiders have traded $AHR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $AHR stock by insiders over the last 6 months:
- JEFFREY T HANSON has made 0 purchases and 3 sales selling 74,788 shares for an estimated $3,644,504.
- MARK E. FOSTER (EVP, GC & Secretary) has made 0 purchases and 2 sales selling 3,500 shares for an estimated $171,129.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERICAN HEALTHCARE REIT Analyst Ratings
Wall Street analysts have issued reports on $AHR in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/20/2026
- Morgan Stanley issued a "Overweight" rating on 11/20/2025
- UBS issued a "Buy" rating on 11/17/2025
- Keybanc issued a "Overweight" rating on 11/13/2025
- Scotiabank issued a "Sector Outperform" rating on 11/13/2025
- RBC Capital issued a "Outperform" rating on 11/12/2025
- Citizens issued a "Market Outperform" rating on 11/10/2025
To track analyst ratings and price targets for AMERICAN HEALTHCARE REIT, check out Quiver Quantitative's $AHR forecast page.
AMERICAN HEALTHCARE REIT Price Targets
Multiple analysts have issued price targets for $AHR recently. We have seen 9 analysts offer price targets for $AHR in the last 6 months, with a median target of $55.0.
Here are some recent targets:
- Michael Lewis from Truist Securities set a target price of $57.0 on 03/13/2026
- Nicholas Yulico from Scotiabank set a target price of $59.0 on 03/11/2026
- Nick Joseph from Citigroup set a target price of $55.0 on 03/02/2026
- Aaron Hecht from Citizens set a target price of $60.0 on 02/05/2026
- Juan Sanabria from BMO Capital set a target price of $55.0 on 01/29/2026
- Ronald Kamdem from Morgan Stanley set a target price of $55.0 on 11/20/2025
- Michael Goldsmith from UBS set a target price of $56.0 on 11/17/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $AHR ticker page for more data.
